Dr. Yvette Halley-Schultz, PhD is an ImmunoSEQ Research Account Manager for Adaptive Biotechnologies, a company whose goal is to meaningfully improve people’s lives by learning from the wisdom of their adaptive immune systems. She attended Texas A&M University where she obtained both her B.S. in Biomedical Science and Ph.D. in Genetics. Her Postdoc was based at West Virginia University in the Department of Wildlife and Fisheries. Her academic career revolved around utilizing molecular genetic, genomic, and population genetic techniques to conserve and manage wild populations.

Dr. Halley-Schultz enjoys working as a RAM because it provides the opportunity to connect with researchers from across academia and see how their projects evolve and grow.

Dr. Matthew Knight, PhD is a Scientific Liaison at Adaptive Biotechnologies based out of Chicago, Illinois. For his undergraduate he attended the University of Washington. In 2019 he obtained his PhD in Microbiology for the University of California, Berkeley where he studied the metabolism of Mycobacterium tuberculosis and the host responses to it. Prior to working for Adaptive, Dr. Knight was a Postdoc at the University of Chicago where his major research focused on influenza vaccine design. He enjoys working as a SL because he has the opportunity to work on projects across a wide array of disease research areas, working closely with both academic and clinical researchers as they design and troubleshoot their experiments.